Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,045 shares at $2.76 ($6K) on 2021-11-04, disclosed to the SEC on 2021-12-03.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.67 | 85 | $227 | 4.0% |
| 2 | $2.63 | 85 | $224 | 4.0% |
| 3 | $2.71 | 85 | $230 | 4.1% |
| 4 | $2.76 | 85 | $235 | 4.2% |
| 5 | $2.71 | 85 | $230 | 4.1% |
| 6 | $2.95 | 85 |
| $251 |
| 4.5% |
| 7 | $3.21 | 85 | $273 | 4.9% |
| 8 | $2.94 | 85 | $250 | 4.5% |
| 9 | $2.83 | 85 | $241 | 4.3% |
| 10 | $2.67 | 85 | $227 | 4.0% |
| 11 | $2.71 | 85 | $230 | 4.1% |
| 12 | $2.66 | 85 | $226 | 4.0% |
| 13 | $2.58 | 85 | $219 | 3.9% |
| 14 | $2.58 | 85 | $219 | 3.9% |
| 15 | $2.55 | 85 | $217 | 3.9% |
| 16 | $2.35 | 85 | $200 | 3.6% |
| 17 | $2.29 | 85 | $195 | 3.5% |
| 18 | $2.31 | 150 | $347 | 6.2% |
| 19 | $2.26 | 150 | $339 | 6.0% |
| 20 | $2.23 | 150 | $335 | 6.0% |
| 21 | $4.61 | 150 | $692 | 12.3% |
| Total | $2.74 avg | 2,045 | $6K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |